Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells - PubMed (original) (raw)
Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells
P Vandenberghe et al. J Exp Med. 1992.
Abstract
CD28 is an adhesion receptor expressed as a 44-kD dimer on the surface of a major subset of human T cells. The CD28 receptor regulates the production of multiple lymphokines, including interleukin 2 (IL-2), by activation of a signal transduction pathway that is poorly understood. Here we show that ligation of CD28 by a monoclonal antibody (mAb) or by a natural ligand, B7/BB1, induces protein tyrosine phosphorylation that is distinct from T cell receptor (TCR)-induced tyrosine phosphorylation. CD28-induced protein tyrosine phosphorylation was greatly enhanced in cells that had been preactivated by ligation of the TCR, or by pretreatment with phorbol esters. Rapid and prolonged tyrosine phosphorylation of a single substrate, pp100, was induced in T cells after interaction with B7/BB1 presented on transfected Chinese hamster ovary (CHO) cells. Anti-B7 mAb inhibited B7/BB1 receptor-induced tyrosine phosphorylation, indicating that B7-CD28 interaction was required. CD28-induced tyrosine phosphorylation was independent of the TCR because it occurred in a variant of the Jurkat T cell line that does not express the TCR. Herbimycin A, a protein tyrosine kinase inhibitor, could prevent CD28-induced tyrosine phosphorylation and CD28-induced IL-2 production in normal T cells. The simultaneous crosslinking of CD28 and CD45, a tyrosine phosphatase, could prevent tyrosine phosphorylation of pp100. These results suggest that specific tyrosine phosphorylation, particularly of pp100, occurs directly as a result of CD28 ligand binding and is involved in transducing the signal delivered through CD28 by accessory cells that express the B7/BB1 receptor. Thus, this particular form of signal transduction may be relevant to lymphokine production and, potentially may provide a means to study the induction of self-tolerance, given the putative role of the costimulatory signal in the induction of T cell activation or anergy.
Similar articles
- Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
Soares LR, Rivas A, Tsavaler L, Engleman EG. Soares LR, et al. J Immunol. 1997 Aug 1;159(3):1115-24. J Immunol. 1997. PMID: 9233604 - CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
Lu Y, Granelli-Piperno A, Bjorndahl JM, Phillips CA, Trevillyan JM. Lu Y, et al. J Immunol. 1992 Jul 1;149(1):24-9. J Immunol. 1992. PMID: 1318900 - Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS. Tan P, et al. J Exp Med. 1993 Jan 1;177(1):165-73. doi: 10.1084/jem.177.1.165. J Exp Med. 1993. PMID: 7678111 Free PMC article. - Multiple signal transduction pathways activated through the T cell receptor for antigen.
Siegel JN, Egerton M, Phillips AF, Samelson LE. Siegel JN, et al. Semin Immunol. 1991 Sep;3(5):325-34. Semin Immunol. 1991. PMID: 1724737 Review. - Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.
Judge TA, Tang A, Turka LA. Judge TA, et al. Immunol Res. 1996;15(1):38-49. doi: 10.1007/BF02918283. Immunol Res. 1996. PMID: 8739564 Review.
Cited by
- B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
Sfikakis PP, Oglesby R, Sfikakis P, Tsokos GC. Sfikakis PP, et al. Clin Exp Immunol. 1994 Apr;96(1):8-14. doi: 10.1111/j.1365-2249.1994.tb06221.x. Clin Exp Immunol. 1994. PMID: 7512010 Free PMC article. - The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
Ghosh P, Tan TH, Rice NR, Sica A, Young HA. Ghosh P, et al. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1696-700. doi: 10.1073/pnas.90.5.1696. Proc Natl Acad Sci U S A. 1993. PMID: 8383323 Free PMC article. - Recent advances and discoveries in the mechanisms and functions of CAR T cells.
Larson RC, Maus MV. Larson RC, et al. Nat Rev Cancer. 2021 Mar;21(3):145-161. doi: 10.1038/s41568-020-00323-z. Epub 2021 Jan 22. Nat Rev Cancer. 2021. PMID: 33483715 Free PMC article. Review. - IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase.
Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W, Schulze-Osthoff K. Los M, et al. EMBO J. 1995 Aug 1;14(15):3731-40. doi: 10.1002/j.1460-2075.1995.tb00043.x. EMBO J. 1995. PMID: 7641692 Free PMC article. - Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
Baxevanis CN, Papamichail M. Baxevanis CN, et al. Cancer Immunol Immunother. 2004 Oct;53(10):893-903. doi: 10.1007/s00262-004-0523-y. Epub 2004 May 26. Cancer Immunol Immunother. 2004. PMID: 15168086 Free PMC article. Review.
References
- Eur J Immunol. 1986 Oct;16(10):1289-96 - PubMed
- Immunol Rev. 1980;51:279-314 - PubMed
- J Exp Med. 1985 Jun 1;161(6):1513-24 - PubMed
- J Immunol. 1982 Feb;128(2):823-7 - PubMed
- J Immunol. 1990 Mar 1;144(5):1591-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous